Arrow struck with Class I recall notice from FDA
This article was originally published in Clinica
Arrow International’s recall of its intra-aortic balloon catheters has been given the most severe type of warning from the US FDA. In October, Arrow warned customers that products among certain lots of its intra-aortic balloon catheter technology could become stuck in their sheaths and not be able to move forward or backwards, potentially causing a delay in therapy, bleeding, or even arterial injury. The recall, which now has been handed a Class I notification by the FDA, also includes Arrow’s intra-aortic balloons. Arrow, an Everett, Massachusetts-based subsidiary of Teleflex Medical, distributed the faulty products from November 2009 until October 2010 but is now urging customers to discontinue use of the malfunctioning devices. The catheters and balloons are used to treat heart failure, septic shock and myocardial infarction.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals